The labeling provided to health professionals (but not to the general public) may contain the following information for ingredients identified in § 357.210: Indication. “For visualization of biliary ducts during cholecystography.”
[54 FR 8321, Feb. 28, 1989]
Title 21 published on 2012-04-01
no entries appear in the Federal Register after this date.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.